# Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma

> **NCT00033293** · PHASE3 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 53 (actual)

## Conditions studied

- Localized Resectable Neuroblastoma
- Localized Unresectable Neuroblastoma
- Regional Neuroblastoma
- Stage 4 Neuroblastoma
- Stage 4S Neuroblastoma

## Interventions

- **OTHER:** Clinical Observation
- **DRUG:** Cyclophosphamide
- **OTHER:** Laboratory Biomarker Analysis
- **PROCEDURE:** Magnetic Resonance Imaging
- **DRUG:** Prednisone
- **BIOLOGICAL:** Therapeutic Immune Globulin

## Key facts

- **NCT ID:** NCT00033293
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03-15
- **Primary completion:** 2013-12-10
- **Final completion:** 2022-12-31
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2023-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00033293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00033293, "Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00033293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*